The Global To Stupefy Growth Of The Small Joint Replacement Market

Posted by Merin John on April 29th, 2021

While road accidents are projected to become the seventh leading cause of death by the end of 2030, WHO also points to a growing number of traumatic instances due to road accidents. On the other side, ASIRT (the Association of System Integrators and Retailers in Technology) says that road accidents injure approximately 50 million people, yearly – translating into severe orthopedic injuries.

In addition, accidents in the field of athletics lead to major or minor orthopedic injuries. Small joint injury forms a major part of the total orthopedic injury scenario, thereby generating the need for small joint replacement therapies.

Get Sample Copy of Report @ https://www.persistencemarketresearch.com/samples/25957

Company Profiles

Wright Medical

Stryker Corporation

Zimmer Biomet

Integra Lifesciences

Johnson & Johnson (Dupey Synthese)

Corin Group

Evolutis Group

KeriMedical SA

Marle SA

A few more factors that play an important role in raising the demand for small joint replacement include aging, severe calcium deficiency, a growing number of low bone density cases, and increasing instances of arthritis and osteoporosis.

PMR Projects a Healthy Growth Outlook for Small Joint Replacement Market

Persistence Market Research recently published a new study on the global small joint replacement landscape, according to which the favorable reimbursement scenario continues to play a pivotal role in propelling the adoption of small joint replacement therapies.

According to the PMR report, the global revenue of small joint replacement market is likely to approach the valuation of US$ 455 million in 2019, at the projected year on year growth of over 6%. Leading companies operating in the global competitive landscape of small joint replacement market are currently focusing on product innovation, strategic collaborations, and geographical market expansion, says the report.

“Small joint replacement therapies come with a set of risks, including loosening of implants, wearing or fracturing over the time, stiffness of joints in the vicinity of operated area, possible internal infection, implant failure leading to severe pain, artificial joint dislocation, and blood vessel or nerve damage. However, reduced hospital stay and faster recovery post the minimally invasive surgical procedure involved in small joint replacement therapies will continue to compel patients to opt for small joint replacement surgeries, boosting the global market growth at a promising pace,” explains a senior research analyst at the company.